Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127907631 | 12790763 | 1 | I | 20160823 | 20160929 | 20160929 | EXP | US-ROCHE-1835021 | ROCHE | 73.00 | YR | F | Y | 73.60000 | KG | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127907631 | 12790763 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | LAST TREATMENT RECEIVED ON 02/MAY/2012 | U | 125085 | 1105 | MG | |||||||
| 127907631 | 12790763 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1105 | MG | ||||||||
| 127907631 | 12790763 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1105 | MG | ||||||||
| 127907631 | 12790763 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1105 | MG | ||||||||
| 127907631 | 12790763 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1105 | MG | ||||||||
| 127907631 | 12790763 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 965 | MG | ||||||||
| 127907631 | 12790763 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 965 | MG | ||||||||
| 127907631 | 12790763 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 965 | MG | ||||||||
| 127907631 | 12790763 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 965 | MG | ||||||||
| 127907631 | 12790763 | 10 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 835 | MG | ||||||||
| 127907631 | 12790763 | 11 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 835 | MG | ||||||||
| 127907631 | 12790763 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 835 | MG | ||||||||
| 127907631 | 12790763 | 13 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 127907631 | 12790763 | 14 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127907631 | 12790763 | 1 | Endometrial cancer |
| 127907631 | 12790763 | 13 | Endometrial cancer |
| 127907631 | 12790763 | 14 | Endometrial cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127907631 | 12790763 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127907631 | 12790763 | Blood bilirubin increased | |
| 127907631 | 12790763 | Neutrophil count decreased | |
| 127907631 | 12790763 | Peripheral motor neuropathy | |
| 127907631 | 12790763 | Peripheral sensory neuropathy | |
| 127907631 | 12790763 | Platelet count decreased | |
| 127907631 | 12790763 | Weight decreased | |
| 127907631 | 12790763 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127907631 | 12790763 | 1 | 20110823 | 0 | ||
| 127907631 | 12790763 | 2 | 20110913 | 0 | ||
| 127907631 | 12790763 | 3 | 20111004 | 0 | ||
| 127907631 | 12790763 | 4 | 20111101 | 0 | ||
| 127907631 | 12790763 | 5 | 20111128 | 0 | ||
| 127907631 | 12790763 | 6 | 20111228 | 0 | ||
| 127907631 | 12790763 | 7 | 20120117 | 0 | ||
| 127907631 | 12790763 | 8 | 20120207 | 0 | ||
| 127907631 | 12790763 | 9 | 20120228 | 0 | ||
| 127907631 | 12790763 | 10 | 20120320 | 0 | ||
| 127907631 | 12790763 | 11 | 20120410 | 0 | ||
| 127907631 | 12790763 | 12 | 20120502 | 0 |